BullishAgent BullishAgent
EDGAR Earnings Ratings Insiders Shorts
ETFs Screener
Sign in Register

LIMN

Liminatus Pharma, Inc. Class A Common Stock NASDAQ Listed May 1, 2025
$3.91
-8.43% vs $4.27
Mkt Cap $92.9M
52w Low $0.10 54.7% of range 52w High $7.07
50d MA $2.80 200d MA $0.98
P/E (TTM) -0.2x
EV/EBITDA —
P/B —
Debt/Equity -0.1x
ROE 104.0%
P/FCF -9.3x
RSI (14) 61.10
ATR (14) $0.28
Beta 0.63
50d MA $2.80
200d MA $0.98
Avg Volume 41.8K
Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.
CIK (SEC)
Phone
213 273 5453
6 Centerpointe Drive · La Palma, CA 90623 · US
Data updated apr 25, 2026 7:13pm · Source: financialmodelingprep.com